Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.45 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.45 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.45 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.45 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18309270 | 0.86 | L3MBTL1 (0.60) | ALDH1A1L3MBTL1KMT2AMEN1CYP1A2 | |
| SCHEMBL11108872 | 0.86 | KMT2A (0.51) | ALDH1A1L3MBTL1KMT2AMEN1CYP1A2 | |
| SCHEMBL2903384 | 0.85 | L3MBTL1 (0.55) | ALDH1A1L3MBTL1KMT2AMEN1CYP1A2 | |
| SCHEMBL9226775 | 0.84 | L3MBTL1 (0.58) | ALDH1A1L3MBTL1KMT2AMEN1CYP1A2 | |
| SCHEMBL23251447 | 0.83 | ALDH1A1 (0.50) | ALDH1A1L3MBTL1KMT2ACYP1A2CYP2C19 | |
| SCHEMBL8047365 | 0.83 | ALDH1A1 (0.50) | ALDH1A1L3MBTL1KMT2ACYP1A2CYP2C19 | |
| SCHEMBL2091375 | 0.83 | KMT2A (0.49) | ALDH1A1L3MBTL1KMT2AMEN1CYP1A2 | |
| SCHEMBL21670118 | 0.83 | ALDH1A1 (0.50) | ALDH1A1L3MBTL1KMT2ACYP1A2CYP2C19 | |
| SCHEMBL18950277 | 0.83 | ALDH1A1 (0.50) | ALDH1A1L3MBTL1KMT2ACYP1A2CYP2C19 | |
| SCHEMBL19122587 | 0.83 | L3MBTL1 (0.56) | ALDH1A1L3MBTL1KMT2ALMNANISCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2925139-B1 | FERMENTED SOIL ADDITIVE | LIQUID FERTILISER SYSTEMS PTY LTD (AU) | 2025-04-30 | — | — | EP | disclosed |
| CN-115010584-B | Method for synthesizing aromatic ketone by iron-catalyzed oxidation of tertiary carbon bond breaking of benzyl position | 南京师范大学 | 2023-12-12 | — | — | CN | disclosed |
| US-11820757-B2 | Antagonists of the muscarinic acetylcholine receptor M4 | VANDERBILT UNIVERSITY (US) | 2023-11-21 | — | — | US | disclosed |
| US-20230364070-A1 | PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | ANTARES THERAPEUTICS, INC. | 2023-11-16 | — | — | US | disclosed |
| US-20230233560-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-07-27 | — | — | US | disclosed |
| US-20230233560-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-07-27 | — | — | US | disclosed |
| EP-3686197-B1 | 2-SUBSTITUTED PYRAZOLE AMINO-4-SUBSTITUTED AMINO-5-PYRIMIDINE FORMAMIDE COMPOUND, COMPOSITION, AND APPLICATION THEREOF | BEIJING SCITECH MQ PHARMACEUTICALS LTD (CN) | 2023-06-21 | — | — | EP | disclosed |
| US-11643404-B2 | Ester substituted ion channel blockers and methods for use | Nocion Therapeutics, Inc. (US) | 2023-05-09 | — | — | US | disclosed |
| US-20230135560-A1 | GEM-DISUBSTITUTED PIPERIDINE MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF | Crinetics Pharmaceuticals, Inc. | 2023-05-04 | — | — | US | disclosed |
| US-20230135560-A1 | GEM-DISUBSTITUTED PIPERIDINE MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF | Crinetics Pharmaceuticals, Inc. | 2023-05-04 | — | — | US | disclosed |
| EP-1818340-A1 | GLYCOPEPTIDE ANTIBIOTIC MONOMER DERIVATIVES | National University Corporation Nagoya University (JP) | 2007-08-15 | — | — | EP | disclosed |
| US-20070149506-A1 | Azepine inhibitors of Janus kinases | INCYTE CORPORATION | 2007-06-28 | — | — | US | disclosed |
| CN-1950699-A | Method for monitoring a polymerization in a three-dimensional sample | 3M INNOVATIVE PROPERTIES CO (US) | 2007-04-18 | — | — | CN | disclosed |
| EP-1587850-A1 | CURING AGENTS FOR CATIONICALLY CURABLE COMPOSITIONS | 3M Innovative Properties Company (US) | 2005-10-26 | — | — | EP | disclosed |
| WO-2004060959-A1 | CURING AGENTS FOR CATIONICALLY CURABLE COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-07-22 | — | — | WO | disclosed |
| EP-1292862-A2 | MULTIPASS MULTIPHOTON ABSORPTION METHOD AND APPARATUS | 3M Innovative Properties Company (US) | 2003-03-19 | — | — | EP | disclosed |
| CN-1357142-A | Optical storage medium | 3M INNOVATIVE PROPERTIES CO (US) | 2002-07-03 | — | — | CN | disclosed |
| WO-2001096961-A2 | MULTIPASS MULTIPHOTON ABSORPTION METHOD AND APPARATUS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-12-20 | — | — | WO | disclosed |
| CN-1074705-C | Coated abrastive article and method of making same | MINNESOTA MINING & MFG (US) | 2001-11-14 | — | — | CN | disclosed |
| CN-1074637-A | Coated abrasive article and preparation method thereof | MINNESOTA MINING & MFG (US) | 1993-07-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11820757-B2 | Antagonists of the muscarinic acetylcholine receptor M4 | CHRM2, CHRM3, CHRM4 | ALDH1A1 1973/4885L3MBTL1 2243/4885KMT2A 2450/4885 |
| US-20230233560-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | CFTR, SCNN1B, SLC26A4 | ALDH1A1 3524/4885L3MBTL1 3997/4885KMT2A 3837/4885 |
| US-20230135560-A1 | GEM-DISUBSTITUTED PIPERIDINE MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF | MC1R, MC3R, MC2R | ALDH1A1 2971/4885L3MBTL1 4621/4885KMT2A 1137/4885 |
| US-20230364070-A1 | PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | ERBB2, EGFR, ERBB3 | ALDH1A1 2594/4885L3MBTL1 4678/4885KMT2A 3203/4885 |
| US-11643404-B2 | Ester substituted ion channel blockers and methods for use | TRPV1, TRPA1, TRPV2 | ALDH1A1 1138/4885L3MBTL1 4810/4885KMT2A 2763/4885 |
| US-20070149506-A1 | Azepine inhibitors of Janus kinases | JAK1, JAK3, JAK2 | ALDH1A1 3705/4885L3MBTL1 2859/4885KMT2A 521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.